Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1353253
                    [Title] => Statins may cut risk of hepatocellular carcinoma
                    [Summary] => 
Statin therapy taken to prevent cardiovascular events also appears to protect against hepatocellular carcinoma, reducing the overall risk for the cancer by 37%, according to the results of a systematic review and meta-analysis.

                    [DatePublished] => 2014-08-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1337565
                    [Title] => Nonalcoholic fatty liver linked to cancer rise
                    [Summary] => 
Nonalcoholic fatty liver disease without cirrhosis appears to be a significant contributor to the rise in the incidence of hepatoCellular carcinoma in the past two decades, according to a study linking population based data from the National Cancer Institute with Medicare enrollment and claim files during 1993-2007.

                    [DatePublished] => 2014-06-22 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 893727
                    [Title] => Screening combo finds HCC in cirrhosis patients
                    [Summary] => 
A combination of ultrasound and alpha-fetoprotein testing identified almost all hepatocellular carcinomas in patients with cirrhosis that was primarily associated with chronic hepatitis C, a retrospective study has shown.

                    [DatePublished] => 2013-01-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 861128
                    [Title] => New developments in liver disease
                    [Summary] => 
The liver disease session featured four highly regarded experts in the field who provided an outstanding overview.

                    [DatePublished] => 2012-10-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 830195
                    [Title] => Diabetes may increase risk of liver cancer
                    [Summary] => 
Diabetes appears to be an independent risk factor for hepatocelluration carcinoma, with the risk of rising as duration of the endocrine disease increases, according to an ongoing, prospective case-control study.
                    [DatePublished] => 2012-07-22 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 541370
                    [Title] => Globe launches HCC Solution for enterprises
                    [Summary] => 
Globe has launched its new Hosted Contact Center (HCC) Solution that would enable enterprises to communicate more effectively with their customers and meet their demands for high service levels.
                    [DatePublished] => 2010-01-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Technology
                    [SectionUrl] => technology
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 413586
                    [Title] => Screening for HCC in high-risk patients key to reducing mortality
                    [Summary] => Enhanced surveillance of at-risk population is critical for the early identification and successful treatment of hepatocellular ...
                    [DatePublished] => 2008-11-09 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 76914
                    [Title] => A new liver may be just the cure for some with cancer of liver, bile ducts
                    [Summary] => 
            
                    [DatePublished] => 2008-08-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 296113
                    [Title] => Prevention of hepatitis C virus-related liver cancer
                    [Summary] => (Hepatocellular carcinoma)


YOUR DOSE OF MEDICINE By Charles C. Chante, MD


                    [DatePublished] => 2005-09-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 294946
                    [Title] => Prevention of hepatitis B virus-related liver cancer  (Hepatocellular carcinoma)
                    [Summary] => The most effective means of preventing hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is to prevent HBV infection via global vaccination of infants. Universal vaccination of newborns has been shown to significantly reduce the incidence of HCC among Taiwanese children. Among HBV carriers, the incidence of HCC was significantly higher in those who were hepatitis B e antigen positive, suggesting that antiviral therapy that results in viral clearance or sustained suppression of HBV replication should reduce the incidence of HCC.
                    [DatePublished] => 2005-09-04 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

HCC

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1353253
                    [Title] => Statins may cut risk of hepatocellular carcinoma
                    [Summary] => 
Statin therapy taken to prevent cardiovascular events also appears to protect against hepatocellular carcinoma, reducing the overall risk for the cancer by 37%, according to the results of a systematic review and meta-analysis.

                    [DatePublished] => 2014-08-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1337565
                    [Title] => Nonalcoholic fatty liver linked to cancer rise
                    [Summary] => 
Nonalcoholic fatty liver disease without cirrhosis appears to be a significant contributor to the rise in the incidence of hepatoCellular carcinoma in the past two decades, according to a study linking population based data from the National Cancer Institute with Medicare enrollment and claim files during 1993-2007.

                    [DatePublished] => 2014-06-22 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 893727
                    [Title] => Screening combo finds HCC in cirrhosis patients
                    [Summary] => 
A combination of ultrasound and alpha-fetoprotein testing identified almost all hepatocellular carcinomas in patients with cirrhosis that was primarily associated with chronic hepatitis C, a retrospective study has shown.

                    [DatePublished] => 2013-01-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 861128
                    [Title] => New developments in liver disease
                    [Summary] => 
The liver disease session featured four highly regarded experts in the field who provided an outstanding overview.

                    [DatePublished] => 2012-10-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 830195
                    [Title] => Diabetes may increase risk of liver cancer
                    [Summary] => 
Diabetes appears to be an independent risk factor for hepatocelluration carcinoma, with the risk of rising as duration of the endocrine disease increases, according to an ongoing, prospective case-control study.
                    [DatePublished] => 2012-07-22 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 541370
                    [Title] => Globe launches HCC Solution for enterprises
                    [Summary] => 
Globe has launched its new Hosted Contact Center (HCC) Solution that would enable enterprises to communicate more effectively with their customers and meet their demands for high service levels.
                    [DatePublished] => 2010-01-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Technology
                    [SectionUrl] => technology
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 413586
                    [Title] => Screening for HCC in high-risk patients key to reducing mortality
                    [Summary] => Enhanced surveillance of at-risk population is critical for the early identification and successful treatment of hepatocellular ...
                    [DatePublished] => 2008-11-09 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 76914
                    [Title] => A new liver may be just the cure for some with cancer of liver, bile ducts
                    [Summary] => 
            
                    [DatePublished] => 2008-08-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 296113
                    [Title] => Prevention of hepatitis C virus-related liver cancer
                    [Summary] => (Hepatocellular carcinoma)


YOUR DOSE OF MEDICINE By Charles C. Chante, MD


                    [DatePublished] => 2005-09-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 294946
                    [Title] => Prevention of hepatitis B virus-related liver cancer  (Hepatocellular carcinoma)
                    [Summary] => The most effective means of preventing hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is to prevent HBV infection via global vaccination of infants. Universal vaccination of newborns has been shown to significantly reduce the incidence of HCC among Taiwanese children. Among HBV carriers, the incidence of HCC was significantly higher in those who were hepatitis B e antigen positive, suggesting that antiviral therapy that results in viral clearance or sustained suppression of HBV replication should reduce the incidence of HCC.
                    [DatePublished] => 2005-09-04 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Statins may cut risk of hepatocellular carcinoma

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | August 3, 2014 - 12:00am

Statin therapy taken to prevent cardiovascular events also appears to protect against hepatocellular carcinoma, reducing the overall risk for the cancer by 37%, according to the results of a systematic review and...

Opinion

Nonalcoholic fatty liver linked to cancer rise

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 22, 2014 - 12:00am

Nonalcoholic fatty liver disease without cirrhosis appears to be a significant contributor to the rise in the incidence of hepatoCellular carcinoma in the past two decades, according to a study linking population...

Opinion

Screening combo finds HCC in cirrhosis patients

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 6, 2013 - 12:00am

A combination of ultrasound and alpha-fetoprotein testing identified almost all hepatocellular carcinomas in patients with cirrhosis that was primarily associated with chronic hepatitis C, a retrospective study has...

Opinion

New developments in liver disease

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | October 28, 2012 - 12:00am

The liver disease session featured four highly regarded experts in the field who provided an outstanding overview.

Opinion

Diabetes may increase risk of liver cancer

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | July 22, 2012 - 12:00am

Diabetes appears to be an independent risk factor for hepatocelluration carcinoma, with the risk of rising as duration of the endocrine disease increases, according to an ongoing, prospective case-control study...

Opinion

Globe launches HCC Solution for enterprises

January 18, 2010 - 12:00am

Globe has launched its new Hosted Contact Center (HCC) Solution that would enable enterprises to communicate more effectively with their customers and meet their demands for high service levels.

Technology

Screening for HCC in high-risk patients key to reducing mortality

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | November 9, 2008 - 12:00am

Enhanced surveillance of at-risk population is critical for the early identification and successful treatment of hepatocellular ...

Opinion

A new liver may be just the cure for some with cancer of liver, bile ducts

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | August 3, 2008 - 12:00am

Opinion

Prevention of hepatitis C virus-related liver cancer

September 11, 2005 - 12:00am

(Hepatocellular carcinoma) YOUR DOSE OF MEDICINE By Charles C. Chante, MD

Opinion

Prevention of hepatitis B virus-related liver cancer (Hepatocellular carcinoma)

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 4, 2005 - 12:00am

The most effective means of preventing hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is to prevent HBV infection via global vaccination of infants. Universal vaccination of newborns has been shown...

Opinion